The Patent Finder

Precedo Pharmaceuticals Co., Ltd.

Also on record
Records under this name other than the patents Precedo Pharmaceuticals Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.

Showing 1 to 4 of 4 · Back to Precedo Pharmaceuticals Co., Ltd.

PatentTitleStatus Expires Confidence
US 10,975,082Inhibitor of FLT3 kinase and use thereof
Lapsed on the fee record
Ended Apr 13, 2025 · From the USPTO record
Lapsed on the fee recordEnded Apr 13, 2025From the USPTO record
US 10,793,543Selective C-KIT kinase inhibitor
Lapsed on the fee record
Ended Oct 6, 2024 · From the USPTO record
Lapsed on the fee recordEnded Oct 6, 2024From the USPTO record
US 10,781,214Kinase inhibitor against wild-type and mutant EGFR
Lapsed on the fee record
Ended Sep 22, 2024 · From the USPTO record
Lapsed on the fee recordEnded Sep 22, 2024From the USPTO record
US 10,350,210EGFR and ALK dual inhibitor
Lapsed on the fee record
Ended Jul 16, 2023 · From the USPTO record
Lapsed on the fee recordEnded Jul 16, 2023From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited